2 unknown. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Unknown 1 |
Follow ginsenoside Rg3: new trials by email Literature Review of ginsenoside Rg3 trials Research Report on ginsenoside Rg3
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Anti-angiogenic Targeted Drugs Plus Rg3 to Improve the Efficacy of TACE for Unresectable Hepatocellular Carcinoma Anti-angiogenic Targeted Drugs, Ginsenoside Rg3, TACE - Hepatocellular Carcinoma | Not applicable | Unknown | Eastern Hepatobiliary Surgery Hospital | 320 | 2020-12-01 | 2020-08-21 |
| Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer Ginsenoside Rg3 plus First-line Chemotherapy, First-line Chemotherapy - Self Efficacy | Phase 2 | Unknown | Hebei Tumor Hospital | 100 | 2012-12-01 | 2014-04-01 |
Eastern Hepatobiliary Surgery Hospital (1) · Hebei Tumor Hospital (1)
China (2)
Wei Liu (1)